Mind & Matter cover image

Psychedelic Chemistry, Magic Mushrooms, Kratom, Gray Market Research Chemicals, Vape Shops | Andrew Chadeayne | 231

Mind & Matter

00:00

Unraveling Psilocybin and Psychedelic Drug Development

This chapter explores the biochemical components of magic mushrooms, specifically psilocybin and beta carbolines, and their effects on metabolism and psychoactive experiences. It discusses the current state of investment and regulatory challenges in the psychedelic industry, focusing on psilocybin's therapeutic potential and the complexities of drug development, especially phase three trials. The chapter reflects on the hesitance within the industry as stakeholders await clearer outcomes from ongoing trials and funding shifts.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app